Royalty Pharma Plc Cl A (RPRX)

Jun 4, 2025, 4:15 PM EDT - 9 hours ago

Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

May 16, 2025, 4:30 PM EDT - 19 days ago

Royalty Pharma Completes the Acquisition of Its External Manager

May 13, 2025, 8:15 AM EDT - 22 days ago

Royalty Pharma to Present at Upcoming Investor Conferences

May 12, 2025, 4:15 PM EDT - 23 days ago

Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition

May 11, 2025, 9:18 PM EDT - 24 days ago

Royalty Pharma: Again, Guidance Raised, Buy Confirmed

May 8, 2025, 12:44 PM EDT - 27 days ago

Royalty Pharma plc (RPRX) Q1 2025 Earnings Call Transcript

May 8, 2025, 7:15 AM EDT - 27 days ago

Royalty Pharma Reports First Quarter 2025 Results

Apr 21, 2025, 4:15 PM EDT - 6 weeks ago

Royalty Pharma Declares Second Quarter 2025 Dividend

Apr 17, 2025, 4:15 PM EDT - 6 weeks ago

Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025

Apr 8, 2025, 4:15 PM EDT - 2 months ago

Royalty Pharma Appoints Vlad Coric, M.D. to the Company's Board of Directors

Mar 27, 2025, 8:15 AM EDT - 2 months ago

Royalty Pharma Announces Upcoming Investor Day

Feb 27, 2025, 4:15 PM EST - 3 months ago

Royalty Pharma to Present at TD Cowen's 45th Annual Health Care Conference

Feb 13, 2025, 11:03 AM EST - 3 months ago

17 Upcoming Dividend Increases, Including 3 Kings

ADM AFL BKH CTSH ED FBP J

Feb 12, 2025, 10:02 PM EST - 4 months ago

Royalty Pharma: Delivering Growth With A Positive Story Ahead

Feb 12, 2025, 6:30 AM EST - 4 months ago

Royalty Pharma Announces R&D Funding Collaboration With Biogen

Feb 11, 2025, 1:40 PM EST - 4 months ago

Royalty Pharma plc (RPRX) Q4 2024 Earnings Call Transcript

Feb 11, 2025, 7:15 AM EST - 4 months ago

Royalty Pharma Reports Q4 and Full Year 2024 Results

Jan 29, 2025, 9:00 AM EST - 4 months ago

Royalty Pharma Announces Sale of MorphoSys Development Funding Bonds

Jan 28, 2025, 4:15 PM EST - 4 months ago

Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

Jan 15, 2025, 3:49 AM EST - 5 months ago

Royalty Pharma: Key Strategic Updates To Be Priced In

Jan 10, 2025, 7:31 AM EST - 5 months ago

Royalty Pharma simplifies corporate structure with $1.1 bln deal

Jan 10, 2025, 7:30 AM EST - 5 months ago

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference

Jan 10, 2025, 7:15 AM EST - 5 months ago

Royalty Pharma Announces Transformative Step in Company's Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program

Jan 9, 2025, 4:15 PM EST - 5 months ago

Royalty Pharma Announces Dividend Increase

Nov 16, 2024, 8:00 AM EST - 7 months ago

Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +

ACB TALO CAAP CASY DLO EME EQC

Nov 14, 2024, 4:30 PM EST - 7 months ago

Royalty Pharma Announces Inaugural Prize for Impact in Healthcare

Nov 9, 2024, 12:46 AM EST - 7 months ago

Royalty Pharma: Massive Opportunity Ahead

Nov 7, 2024, 7:10 AM EST - 7 months ago

Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million

Nov 6, 2024, 12:28 PM EST - 7 months ago

Royalty Pharma plc (RPRX) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 8:39 AM EST - 7 months ago

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields

JNJ MDT

Nov 6, 2024, 7:15 AM EST - 7 months ago

Royalty Pharma Reports Third Quarter 2024 Results

Nov 4, 2024, 4:15 PM EST - 7 months ago

Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo

Nov 4, 2024, 4:01 PM EST - 7 months ago

Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™

SNDX

Oct 16, 2024, 4:15 PM EDT - 8 months ago

Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024

Oct 11, 2024, 8:15 AM EDT - 8 months ago

Royalty Pharma Declares Fourth Quarter 2024 Dividend

Sep 3, 2024, 5:14 PM EDT - 9 months ago

Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement

Aug 28, 2024, 4:15 PM EDT - 10 months ago

Royalty Pharma to Present at Morgan Stanley's 22nd Annual Global Healthcare Conference

Aug 22, 2024, 3:04 AM EDT - 10 months ago

Royalty Pharma plc Q2: Beat And Raise Reaffirm Our Buy Rating

Aug 11, 2024, 6:33 PM EDT - 10 months ago

Royalty Pharma: Busy Putting Capital To Work

Aug 8, 2024, 2:14 PM EDT - 10 months ago

Royalty Pharma plc (RPRX) Q2 2024 Earnings Call Transcript

Jul 24, 2024, 8:30 AM EDT - 11 months ago

Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital

Jul 19, 2024, 8:15 AM EDT - 11 months ago

Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024

Jul 17, 2024, 4:15 PM EDT - 11 months ago

Royalty Pharma Declares Third Quarter 2024 Dividend

Jun 4, 2024, 4:15 PM EDT - 1 year ago

Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Jun 3, 2024, 5:15 PM EDT - 1 year ago

Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes

May 28, 2024, 7:10 AM EDT - 1 year ago

Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million

May 22, 2024, 4:10 PM EDT - 1 year ago

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

May 9, 2024, 1:32 PM EDT - 1 year ago

Royalty Pharma PLC (RPRX) Q1 2024 Earnings Call Transcript

May 9, 2024, 6:45 AM EDT - 1 year ago

Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab

May 2, 2024, 4:01 PM EDT - 1 year ago

Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma

ARWR